Lopes G - Search Results

1

Perspectives: Neutrophil-to-lymphocyte Ratio as a Potential Biomarker in Immune Checkpoint Inhibitor for Non-Small-Cell Lung Cancer.

Park W, Lopes G. Park W, et al. Among authors: lopes g. Clin Lung Cancer. 2019 May;20(3):143-147. doi: 10.1016/j.cllc.2018.12.003. Epub 2018 Dec 19. Clin Lung Cancer. 2019. PMID: 30683629

2

Efficacy and safety of oxaliplatin and docetaxel in patients with locally advanced and metastatic non-small-cell lung cancer (NSCLC).

Raez LE, Santos ES, Lopes G, Rosado MF, Negret LM, Rocha-Lima C, Tolba K, Farfan N, Hamilton-Nelson K, Silva O, Roman E. Raez LE, et al. Among authors: lopes g. Lung Cancer. 2006 Sep;53(3):347-53. doi: 10.1016/j.lungcan.2006.05.023. Epub 2006 Jul 17. Lung Cancer. 2006. PMID: 16844257 Clinical Trial.

3

Challenges in Facing the Lung Cancer Epidemic and Treating Advanced Disease in Latin America.

Raez LE, Santos ES, Rolfo C, Lopes G, Barrios C, Cardona A, Mas LA, Arrieta O, Richardet E, Vallejos S C, Wistuba I, Gandara D, Hirsch FR. Raez LE, et al. Among authors: lopes g. Clin Lung Cancer. 2017 Jan;18(1):e71-e79. doi: 10.1016/j.cllc.2016.05.003. Epub 2016 Jun 5. Clin Lung Cancer. 2017. PMID: 27426974 Review.

4

Comparative effectiveness of immune-checkpoint inhibitors for previously treated advanced non-small cell lung cancer - A systematic review and network meta-analysis of 3024 participants.

Tan PS, Aguiar P Jr, Haaland B, Lopes G. Tan PS, et al. Among authors: lopes g. Lung Cancer. 2018 Jan;115:84-88. doi: 10.1016/j.lungcan.2017.11.017. Epub 2017 Nov 22. Lung Cancer. 2018. PMID: 29290267

5

Developing a Predictive Model for Clinical Outcomes of Advanced Non-Small Cell Lung Cancer Patients Treated With Nivolumab.

Park W, Kwon D, Saravia D, Desai A, Vargas F, El Dinali M, Warsch J, Elias R, Chae YK, Kim DW, Warsch S, Ishkanian A, Ikpeazu C, Mudad R, Lopes G, Jahanzeb M. Park W, et al. Among authors: lopes g. Clin Lung Cancer. 2018 May;19(3):280-288.e4. doi: 10.1016/j.cllc.2017.12.007. Epub 2017 Dec 21. Clin Lung Cancer. 2018. PMID: 29336998

6

Cost-effectiveness of immune checkpoint inhibitors in NSCLC according to PD-L1 expression.

Aguiar P Jr, Perry LA, Lopes GL Jr. Aguiar P Jr, et al. Lung Cancer Manag. 2016 Nov;5(3):119-122. doi: 10.2217/lmt-2016-0016. Epub 2016 Nov 3. Lung Cancer Manag. 2016. PMID: 30643555 Free PMC article. No abstract available.

7

Clinical Implications of Circulating Tumor DNA Tumor Mutational Burden (ctDNA TMB) in Non-Small Cell Lung Cancer.

Chae YK, Davis AA, Agte S, Pan A, Simon NI, Iams WT, Cruz MR, Tamragouri K, Rhee K, Mohindra N, Villaflor V, Park W, Lopes G, Giles FJ. Chae YK, et al. Among authors: lopes g. Oncologist. 2019 Jun;24(6):820-828. doi: 10.1634/theoncologist.2018-0433. Epub 2019 Mar 13. Oncologist. 2019. PMID: 30867242 Free PMC article.

8

Advanced-Stage Non-Small Cell Lung Cancer: Advances in Thoracic Oncology 2018.

Remon J, Ahn MJ, Girard N, Johnson M, Kim DW, Lopes G, Pillai RN, Solomon B, Villacampa G, Zhou Q. Remon J, et al. Among authors: lopes g. J Thorac Oncol. 2019 Jul;14(7):1134-1155. doi: 10.1016/j.jtho.2019.03.022. Epub 2019 Apr 16. J Thorac Oncol. 2019. PMID: 31002952 Free article. Review.

9

Clinical and Immunological Implications of Frameshift Mutations in Lung Cancer.

Chae YK, Viveiros P, Lopes G, Sukhadia B, Sheikh MM, Saravia D, Florou V, Sokol ES, Frampton GM, Chalmers ZR, Ali SM, Ross JS, Chang S, Wang S, Chiec L, Rahbari A, Mohindra N, Villaflor V, Shin SH, Oh M, Anker J, Park LC, Wang V, Chuang J, Park W. Chae YK, et al. Among authors: lopes g. J Thorac Oncol. 2019 Oct;14(10):1807-1817. doi: 10.1016/j.jtho.2019.06.016. Epub 2019 Jun 22. J Thorac Oncol. 2019. PMID: 31238177 Free article.

10

Safety and efficacy of pembrolizumab monotherapy in elderly patients with PD-L1-positive advanced non-small-cell lung cancer: Pooled analysis from the KEYNOTE-010, KEYNOTE-024, and KEYNOTE-042 studies.

Nosaki K, Saka H, Hosomi Y, Baas P, de Castro G Jr, Reck M, Wu YL, Brahmer JR, Felip E, Sawada T, Noguchi K, Han SR, Piperdi B, Kush DA, Lopes G. Nosaki K, et al. Among authors: lopes g. Lung Cancer. 2019 Sep;135:188-195. doi: 10.1016/j.lungcan.2019.07.004. Epub 2019 Jul 8. Lung Cancer. 2019. PMID: 31446994

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

933 results

Search Page

Filters